BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 23102015)

  • 1. [Xp11.2 translocation renal carcinoma in adults over 50 years of age: about four cases].
    Arnoux V; Long JA; Fiard G; Pasquier D; Bensaadi L; Terrier N; Rambeaud JJ; Descotes JL
    Prog Urol; 2012 Nov; 22(15):932-7. PubMed ID: 23102015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adult Xp11 translocation renal cell carcinoma diagnosed by cytogenetics and immunohistochemistry.
    Komai Y; Fujiwara M; Fujii Y; Mukai H; Yonese J; Kawakami S; Yamamoto S; Migita T; Ishikawa Y; Kurata M; Nakamura T; Fukui I
    Clin Cancer Res; 2009 Feb; 15(4):1170-6. PubMed ID: 19228722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal Cell Carcinoma Associated with Xp11.2 Translocation/TFE3 Gene Fusions: Clinical Features, Treatments and Prognosis.
    Liu N; Wang Z; Gan W; Xiong L; Miao B; Chen X; Guo H; Li D
    PLoS One; 2016; 11(11):e0166897. PubMed ID: 27893792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Xp11 translocation renal cell carcinoma in adults: expanded clinical, pathologic, and genetic spectrum.
    Argani P; Olgac S; Tickoo SK; Goldfischer M; Moch H; Chan DY; Eble JN; Bonsib SM; Jimeno M; Lloreta J; Billis A; Hicks J; De Marzo AM; Reuter VE; Ladanyi M
    Am J Surg Pathol; 2007 Aug; 31(8):1149-60. PubMed ID: 17667536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal cell carcinoma associated with transcription factor E3 expression and Xp11.2 translocation: incidence, characteristics, and prognosis.
    Klatte T; Streubel B; Wrba F; Remzi M; Krammer B; de Martino M; Waldert M; Marberger M; Susani M; Haitel A
    Am J Clin Pathol; 2012 May; 137(5):761-8. PubMed ID: 22523215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The preliminary experiences of translocation renal cell carcinoma and literature review.
    Su HH; Sung MT; Chiang PH; Cheng YT; Chen YT
    Kaohsiung J Med Sci; 2014 Aug; 30(8):402-8. PubMed ID: 25002378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered transcription factor E3 expression in unclassified adult renal cell carcinoma indicates adverse pathological features and poor outcome.
    Mir MC; Trilla E; de Torres IM; Panizo A; Zlotta AR; Van Rhijn B; Morote J
    BJU Int; 2011 Jul; 108(2 Pt 2):E71-6. PubMed ID: 21070573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term survival in a patient with node-positive adult-onset Xp11.2 translocation renal cell carcinoma.
    Aoyagi T; Shinohara N; Kubota-Chikai K; Kuroda N; Nonomura K
    Urol Int; 2011; 86(4):487-90. PubMed ID: 21335945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Renal carcinoma associated with MiTF/TFE translocation: report of six cases in young adults].
    Hintzy MC; Camparo P; Vasiliu V; Peyromaure M; Vieillefond A
    Prog Urol; 2008 May; 18(5):275-80. PubMed ID: 18538271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An aggressive course of Xp11 translocation renal cell carcinoma in a 28-year-old man.
    Koie T; Yoneyama T; Hashimoto Y; Kamimura N; Kusumi T; Kijima H; Ohyama C
    Int J Urol; 2009 Mar; 16(3):333-5. PubMed ID: 19298350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathological features of Xp11.2 translocation renal cell carcinoma.
    Lim B; You D; Jeong IG; Kwon T; Hong S; Song C; Cho YM; Hong B; Hong JH; Ahn H; Kim CS
    Korean J Urol; 2015 Mar; 56(3):212-7. PubMed ID: 25763125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel case of t(X;1)(p11.2;p34) in a renal cell carcinoma with TFE3 rearrangement and favorable outcome in a 57-year-old patient.
    Haudebourg J; Hoch B; Fabas T; Burel-Vandenbos F; Carpentier X; Amiel J; Cardot-Leccia N; Michiels JF; Pedeutour F
    Cancer Genet Cytogenet; 2010 Jul; 200(2):75-8. PubMed ID: 20620589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Xp11.2 translocation renal carcinoma with placental metastasis: a case report.
    Bovio IM; Allan RW; Oliai BR; Hampton T; Rush DS
    Int J Surg Pathol; 2011 Feb; 19(1):80-3. PubMed ID: 19164407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal cell carcinoma in children and young adults: analysis of clinicopathological, immunohistochemical and molecular characteristics with an emphasis on the spectrum of Xp11.2 translocation-associated and unusual clear cell subtypes.
    Wu A; Kunju LP; Cheng L; Shah RB
    Histopathology; 2008 Nov; 53(5):533-44. PubMed ID: 18983462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An adult case of melanotic Xp11 translocation renal cancers: distinct entity or sub-entity?
    Varinot J; Camparo P; Beurtheret S; Barreda E; Compérat E
    Int J Surg Pathol; 2011 Jun; 19(3):285-9. PubMed ID: 21427096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pediatric renal carcinoma associated with Xp11.2 translocations/TFE3 gene fusions and clinicopathologic associations.
    Altinok G; Kattar MM; Mohamed A; Poulik J; Grignon D; Rabah R
    Pediatr Dev Pathol; 2005; 8(2):168-80. PubMed ID: 15747097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pediatric renal cell carcinoma: clinical, pathologic, and molecular abnormalities associated with the members of the mit transcription factor family.
    Ramphal R; Pappo A; Zielenska M; Grant R; Ngan BY
    Am J Clin Pathol; 2006 Sep; 126(3):349-64. PubMed ID: 16880148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A case of xp11.2 translocation renal cell carcinoma].
    Horie K; Kikuchi M; Miwa K; Minamidate Y; Yokoi S; Nakano M; Deguchi T; Ehara H; Asano N; Hirose Y
    Hinyokika Kiyo; 2011 Mar; 57(3):129-33. PubMed ID: 21586884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal translocation carcinomas: clinicopathologic, immunohistochemical, and gene expression profiling analysis of 31 cases with a review of the literature.
    Camparo P; Vasiliu V; Molinie V; Couturier J; Dykema KJ; Petillo D; Furge KA; Comperat EM; Lae M; Bouvier R; Boccon-Gibod L; Denoux Y; Ferlicot S; Forest E; Fromont G; Hintzy MC; Laghouati M; Sibony M; Tucker ML; Weber N; Teh BT; Vieillefond A
    Am J Surg Pathol; 2008 May; 32(5):656-70. PubMed ID: 18344867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Validation of a TFE3 break-apart FISH assay for Xp11.2 translocation renal cell carcinomas.
    Mosquera JM; Dal Cin P; Mertz KD; Perner S; Davis IJ; Fisher DE; Rubin MA; Hirsch MS
    Diagn Mol Pathol; 2011 Sep; 20(3):129-37. PubMed ID: 21817901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.